Cara Therapeutics Depreciation & Amortization 2011-2026 | CARA

Annual Depreciation & Amortization Cara Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
95 K	95 K	259 K	248 K	248 K	209 K	198 K	370 K	495 K	1.46 M	839 K	783 K	789 K	1.02 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.46 M	95 K	508 K

Quarterly Depreciation & Amortization Cara Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	42 K	-	-	-	58 K	-	187 K	126 K	63 K	-	186 K	124 K	63 K	-	147 K	96 K	48 K	-	150 K	100 K	50 K	-	318 K	239 K	125 K	-	370 K	245 K	122 K	-	1.35 M	1.25 M	730 K	-	580 K	386 K	193 K	-	590 K	393 K	197 K	-	592 K	395 K	198 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.35 M	42 K	303 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Aptorum Group Limited APM	1.13 M	$ 0.89	1.48 %	$ 6.54 M	China
ACADIA Pharmaceuticals ACAD	920 K	$ 22.2	-2.07 %	$ 3.68 B	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
ImmuCell Corporation ICCC	2.78 M	$ 8.44	1.08 %	$ 76.2 M	USA
Innoviva INVA	26.3 M	$ 23.05	-2.7 %	$ 1.55 B	USA
Jaguar Health JAGX	1.91 M	$ 0.23	-6.64 %	$ 536 K	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.05	-0.98 %	$ 433 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 22.37	-3.95 %	$ 2.85 B	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.41	-4.73 %	$ 375 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.98	2.41 %	$ 4.91 M	Israel
Madrigal Pharmaceuticals MDGL	1.51 M	$ 518.58	0.37 %	$ 11.6 B	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA